New US nod for Roche's Tecentriq in NSCLC

19th May 2020 Uncategorised 0

This is Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the US

More: New US nod for Roche's Tecentriq in NSCLC
Source: News